(19)
(11) EP 1 814 599 A2

(12)

(88) Date of publication A3:
03.08.2006

(43) Date of publication:
08.08.2007 Bulletin 2007/32

(21) Application number: 05782173.8

(22) Date of filing: 03.08.2005
(51) International Patent Classification (IPC): 
A61K 51/06(2006.01)
(86) International application number:
PCT/US2005/027800
(87) International publication number:
WO 2006/017688 (16.02.2006 Gazette 2006/07)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK YU

(30) Priority: 03.08.2004 US 598031 P

(71) Applicant: Biorexis Pharmaceutical Corporation
King of Prussia, PA 19406-2675 (US)

(72) Inventors:
  • SADEGHI, Homayoun
    King of Prussia, PA 19406 (US)
  • PRIOR, Christopher
    King of Prussia, PA 19406 (US)
  • BALLANCE, David, J.
    King of Prussia, PA 19406 (US)

(74) Representative: Cripps, Joanna Elizabeth et al
Mewburn Ellis LLP York House 23 Kingsway
London WC2B 6HP
London WC2B 6HP (GB)

   


(54) COMBINATION THERAPY USING TRANSFERRIN FUSION PROTEINS COMPRISING GLP-1